Trial Outcomes & Findings for Kovanaze Vs. Articaine in Achieving Pulpal Anesthesia of Maxillary Teeth - Pediatric (NCT NCT03962634)

NCT ID: NCT03962634

Last Updated: 2020-11-19

Results Overview

% dental procedures completed without the need for rescue anesthesia

Recruitment status

TERMINATED

Study phase

PHASE2

Target enrollment

3 participants

Primary outcome timeframe

immediately after dental procedure, an average of 3 hours

Results posted on

2020-11-19

Participant Flow

Participant milestones

Participant milestones
Measure
Kovanaze Nasal Spray (Pediatrics)
Children \>20 kg who require pulpotomy, restorative procedures, SS crowns in one maxillary tooth Kovanaze Nasal Spray: Intra-nasal local anesthetic
Articaine Injections (Pediatrics)
Children \>20 kg who require pulpotomy, restorative procedures, or stainless steel crowns in one maxillary tooth Articaine Injection: Local anesthetic
Overall Study
STARTED
1
2
Overall Study
COMPLETED
1
2
Overall Study
NOT COMPLETED
0
0

Reasons for withdrawal

Withdrawal data not reported

Baseline Characteristics

Because of the low number of enrollees with only 1 in the treatment group, results are not reported to protect the confidentiality of the participants

Baseline characteristics by cohort

Baseline characteristics by cohort
Measure
Kovanaze Nasal Spray (Pediatrics)
n=1 Participants
Children \>20 kg who require pulpotomy, restorative procedures, SS crowns in one maxillary tooth Kovanaze Nasal Spray: Intra-nasal local anesthetic
Articaine Injections (Pediatrics)
n=2 Participants
Children \>20 kg who require pulpotomy, restorative procedures, or stainless steel crowns in one maxillary tooth Articaine Injection: Local anesthetic
Total
n=3 Participants
Total of all reporting groups
Sex: Female, Male
Female
0 Participants
Because of the low number of enrollees with only 1 in the treatment group, results are not reported to protect the confidentiality of the participants
0 Participants
Because of the low number of enrollees with only 1 in the treatment group, results are not reported to protect the confidentiality of the participants
0 Participants
Because of the low number of enrollees with only 1 in the treatment group, results are not reported to protect the confidentiality of the participants
Sex: Female, Male
Male
0 Participants
Because of the low number of enrollees with only 1 in the treatment group, results are not reported to protect the confidentiality of the participants
0 Participants
Because of the low number of enrollees with only 1 in the treatment group, results are not reported to protect the confidentiality of the participants
0 Participants
Because of the low number of enrollees with only 1 in the treatment group, results are not reported to protect the confidentiality of the participants
Race and Ethnicity Not Collected
0 Participants
Race and Ethnicity were not collected from any participant.
Region of Enrollment
United States
1 participants
n=1 Participants
2 participants
n=2 Participants
3 participants
n=3 Participants

PRIMARY outcome

Timeframe: immediately after dental procedure, an average of 3 hours

Population: Because of the low number of enrollees with only 1 in the treatment group, results are not reported to protect the confidentiality of the participants

% dental procedures completed without the need for rescue anesthesia

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: immediately after dental procedure, an average of 3 hours

Population: Because of the low number of enrollees with only 1 in the treatment group, results are not reported to protect the confidentiality of the participants

Number of teeth anesthetized in maxillary arch

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: from baseline to immediately after dental procedure

Population: Because of the low number of enrollees with only 1 in the treatment group, results are not reported to protect the confidentiality of the participants

STAI-Y6 - 6 item youth questionnaire assessing anxiety on a 4 point scale ranging from 1 (Not at all) to 4 (very much). Scores range from 6 to 24.

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: immediately after dental procedure, an average of 3 hours

Population: Because of the low number of enrollees with only 1 in the treatment group, results are not reported to protect the confidentiality of the participants

Venham Behavior rating scale - single item 6 point scale used by provider to rate child's behavior during treatment. Item ranges from 0 (no protest) to 5 (high protest, no cooperation from child)

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: from baseline to immediately after dental procedure

Population: Because of the low number of enrollees with only 1 in the treatment group, results are not reported to protect the confidentiality of the participants

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: from baseline to immediately after dental procedure

Population: Because of the low number of enrollees with only 1 in the treatment group, results are not reported to protect the confidentiality of the participants

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: from baseline to immediately after dental procedure

Population: Because of the low number of enrollees with only 1 in the treatment group, results are not reported to protect the confidentiality of the participants

Emoji scale ranging from 1 (very negative face) to 7 (very positive face)

Outcome measures

Outcome data not reported

Adverse Events

Kovanaze Nasal Spray (Pediatrics)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Articaine Injections (Pediatrics)

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

Parthasarathy Madurantakam

Virginia Commonwealth University

Phone: 804-828-4953

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place